mersenne− twister random number generator (SYSTAT)
90
Structured Review
SYSTAT
mersenne− twister random number generator
Mersenne− Twister Random Number Generator, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mersenne%E2%88%92+twister+random+number+generator/mersenne++twister+random+number+generator/pm33275847-118-41-47
Average 90 stars, based on 1 article reviews
Mersenne− Twister Random Number Generator, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mersenne%E2%88%92+twister+random+number+generator/mersenne++twister+random+number+generator/pm33275847-118-41-47
Average 90 stars, based on 1 article reviews
mersenne− twister random number generator - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Generated:Article Title: Identifying Synthetic Lectins from a Competitive Screen for the Detection of Prostate Cancer. Article Snippet: Herein, we report a dual dye competitive screening method for the identification of five boronic acid functionalized synthetic lectins (SLs) that are selective for prostate-associated targets with the goal of detecting and staging prostate cancer.. This method uses differently labeled normal (RWEP-1) and diseased (PC3) cell membrane extracts in a competitive binding assay to identify SLs that bind either the cancerous or normal extracts but not both.. Subsequent studies examined the efficacy of these new SL hits in an array format to discriminate six prostate cell lines. Sampling:Article Title: Identifying Synthetic Lectins from a Competitive Screen for the Detection of Prostate Cancer. Article Snippet: Herein, we report a dual dye competitive screening method for the identification of five boronic acid functionalized synthetic lectins (SLs) that are selective for prostate-associated targets with the goal of detecting and staging prostate cancer.. This method uses differently labeled normal (RWEP-1) and diseased (PC3) cell membrane extracts in a competitive binding assay to identify SLs that bind either the cancerous or normal extracts but not both.. Subsequent studies examined the efficacy of these new SL hits in an array format to discriminate six prostate cell lines. |